Global Voice/Vocal Biomarker Market Size is valued at US$ 1.1 Bn in 2024 and is predicted to reach US$ 4.2 Bn by the year 2034 at an 14.2% CAGR during the forecast period for 2025-2034.
The Voice/Vocal Biomarker is a method that analyses, records, and locates unprocessed speech sounds, enabling machines to recognise and understand human emotions. Anxiety, depression, and atherosclerotic coronary heart disease are among the conditions linked to biomarkers in the speaker biomarkers. This technology allows voice-powered gadgets and applications to communicate emotionally, exactly like people, by instantly translating the tones of human voices into their underlying emotions.
The rising frequency of mental and cardiovascular ailments, the growing need for less invasive therapies to detect various illnesses, and the increasing prevalence of Parkinson's disease and other conditions are all expected to fuel the growth of the global voice/vocal biomarkers market during the forecast period.
Additionally, recent developments in voice/vocal biomarkers have focused on analysing and interpreting voice data using machine learning (ML) and artificial intelligence (AI) technologies. The use of voice/vocal biomarkers for a broader range of purposes, like tracking neurological and pulmonary conditions, is also being examined by researchers and developers. Additionally, there is a rising emphasis on the development of wearable technology and mobile applications for managing and analysing voice data, allowing remote monitoring and providing immediate feedback. An additional trend driving the growth of the voice/vocal biomarker market is the integration of speech biomarkers with other biometric technologies, such as heart rate monitoring and facial recognition, to deliver a more exhaustive approach to disease diagnosis and health monitoring.
Some of the Key Players in Voice/Vocal Biomarker Market:
· audEERING GmbH
· Biosensics
· Canary Speech, Inc.
· Evocal Health GmbH
· Kintsugi Mindful Wellness, Inc.
· PST Inc.
· Sonde Health
· Sound Health
· VoiceMed Italia srl
· Zana Technologies GmbH
The voice/vocal biomarker market is segmented by platform type, indication type, application, and end user. By platform type, the market is segmented into cloud-based and web-based. By indication type, the market is segmented into respiratory diseases, neurological disorder, cardiovascular disease, mental health disorder, and others. By application, the market is segmented into diagnostics, clinical research, monitoring, and others. By end user, the market is segmented into hospitals, research institutions, and CROs.
The rising global incidence of neurological diseases such as parkinson's disease, alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS) is the principal driver of the growth of the neurological disorder segment in the voice/vocal biomarker market. Voice analysis software can be used to identify such issues because they often result in changes in speech patterns, tone, pitch, and articulation. As conventional diagnostic methods such as MRI or PET scans are often expensive, invasive, and time-consuming, the increasing demand for early, non-invasive, and low-cost diagnostic tools is also accelerating the use of vocal biomarkers. In addition, advancements in machine learning (ML), artificial intelligence (AI), and natural language processing (NLP) continue to enhance the accuracy of voice-based algorithms, enabling the diagnosis and monitoring of neurological impairments using subtle speech nuances.
The diagnostics category dominated the voice/vocal biomarkers market globally in 2024. The technology's non-invasive nature, capacity to identify early disease symptoms, and function in ongoing patient health monitoring are what propel the diagnostic applications in the vocal/voice biomarkers market. Voice/vocal biomarkers provide a scalable, affordable, and easily accessible method to enhance the precision and timeliness of disease identification, particularly for neurological and respiratory disorders, thanks to advancements in artificial intelligence, machine learning, and remote healthcare. These diagnostic applications are anticipated to expand further as clinical validation advances and the technology is more thoroughly integrated into healthcare systems, providing substantial benefits to patients and healthcare professionals.
In 2024, the global voice/vocal biomarker market was dominated by North America, driven by a growing number of psychological concerns. Over 6 million people have Alzheimer's disease, according to the Alzheimer's Association. This figure is expected to increase to almost 13 million by 2050, necessitating faster biomarker research for Alzheimer's disease early detection. Additionally, regulations pertaining to medical reimbursement and the region's rising healthcare costs encourage the growth of the voice/vocal biomarker market.
Moreover, Europe is the second-largest region in the global voice/vocal biomarkers market due to growing healthcare costs and increased awareness in this area. The application of artificial intelligence (AI) for sound analysis in risk prediction, diagnosis, and remote monitoring of various clinical outcomes and symptoms, as well as for health-related objectives, is becoming increasingly well-known in the European region. The voice/vocal biomarkers and other artificial intelligence (AI)-based voice analysis have thus opened up new avenues for the European healthcare industry. Consequently, several businesses are focusing on launching new voice analysis technologies.
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Voice/Vocal Biomarker Market Snapshot
Chapter 4. Global Voice/Vocal Biomarker Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on Voice/Vocal Biomarker Market Industry Trends
4.10. Global Voice/Vocal Biomarker Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
Chapter 5. Voice/Vocal Biomarker Market Segmentation 1: By Platform Type, Estimates & Trend Analysis
5.1. Market Share by Platform Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Platform Type:
5.2.1. Cloud-based
5.2.2. Web-based
Chapter 6. Voice/Vocal Biomarker Market Segmentation 2: Indication Type, Estimates & Trend Analysis
6.1. Market Share by Indication Type, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication Type:
6.2.1. Neurological Disorder
6.2.2. Mental Health Disorder
6.2.3. Respiratory Diseases
6.2.4. Cardiovascular Disease
6.2.5. Others
Chapter 7. Voice/Vocal Biomarker Market Segmentation 3: By Application Type, Estimates & Trend Analysis
7.1. Market Share by Application Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application Type:
7.2.1. Diagnostics
7.2.2. Monitoring
7.2.3. Clinical Research
7.2.4. Others
Chapter 8. Voice/Vocal Biomarker Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals
8.2.2. CROs
8.2.3. Research Institutions
Chapter 9. Voice/Vocal Biomarker Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Voice/Vocal Biomarker Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.2.3. North America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Indication Type, 2021-2034
9.2.4. North America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Application Type, 2021-2034
9.2.5. North America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.2.6. North America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.3.3. Europe Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Indication Type, 2021-2034
9.3.4. Europe Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Application Type, 2021-2034
9.3.5. Europe Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.4.3. Asia Pacific Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Indication Type, 2021-2034
9.4.4. Asia Pacific Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Application Type, 2021-2034
9.4.5. Asia Pacific Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.5.3. Latin America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Indication Type, 2021-2034
9.5.4. Latin America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Application Type, 2021-2034
9.5.5. Latin America Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.6.3. Middle East & Africa Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Indication Type, 2021-2034
9.6.4. Middle East & Africa Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by Application Type, 2021-2034
9.6.5. Middle East & Africa Voice/Vocal Biomarker Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Sonde Health
10.2.1.1. Business Overview
10.2.1.2. Key Product /Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Canary Speech
10.2.3. Ellipsis Health
10.2.4. auddering GmbH
10.2.5. Cogito Tech
10.2.6. Kintsugi
10.2.7. Beyond Verbal
Voice/Vocal Biomarker Market by Platform Type-
· Cloud-based
· Web-based
Voice/Vocal Biomarker Market by Indication Type -
· Respiratory Diseases
· Neurological Disorder
· Cardiovascular Disease
· Mental Health Disorder
· Others
Voice/Vocal Biomarker Market by Application-
· Diagnostics
· Clinical Research
· Monitoring
· Others
Voice/Vocal Biomarker Market by End User-
· Hospitals
· Research Institutions
· CROs
Voice/Vocal Biomarker Market by Region-
North America-
· The US
· Canada
Europe-
· Germany
· The UK
· France
· Italy
· Spain
· Rest of Europe
Asia-Pacific-
· China
· Japan
· India
· South Korea
· Southeast Asia
· Rest of Asia Pacific
Latin America-
· Brazil
· Argentina
· Mexico
· Rest of Latin America
Middle East & Africa-
· GCC Countries
· South Africa
· Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
